Better health is associated with a higher risk of heart disease.

Published Date: 17 Feb 2023

UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...

Read Full News

Latest News

Left Main CAD: Can New 10-Year Data Settle the Debate?

Ten-year follow-up data show similar mortality with PCI and CABG in selected patients, adding new evidence to the long-standing revascularization debate.

Could Dedicated Women’s Heart Centers Close Care Gaps?

Experts call for more women’s Heart Centers across Europe, citing persistent disparities in cardiovascular diagnosis, treatment, and outcomes.

Finerenone May Cut Sudden Death Risk Across the CKM Spectrum

Finerenone treatment is associated with a reduced risk for sudden death among adults with chronic kidney disease, type 2 diabetes, or heart failure, study finds.

Med Op-Ed: Dying of Old Age, Gambling Screening, and More

A leading cause of death in Japan does not follow global medical conventions; why primary care clinicians should screen for gambling disorder; and a trial refutes vitamin C as a treatment for severe burns.

What Anxiety and Depression Signal in Atrial Fibrillation

Anxiety and depression are linked to a higher risk for death and major adverse cardiovascular events, with a greater risk at higher symptom severity, prompting closer attention in routine care.

The Evolving Landscape of Sickle Cell Disease Treatment

Gene therapy and small molecules are opening the door to new curative approaches, but access continues to be a barrier for most patients.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Latest News

Ten-year follow-up data show similar mortality with PCI and CABG in selected patients, adding new evidence to the long-standing revascularization debate.

Experts call for more women’s Heart Centers across Europe, citing persistent disparities in cardiovascular diagnosis, treatment, and outcomes.

Finerenone treatment is associated with a reduced risk for sudden death among adults with chronic kidney disease, type 2 diabetes, or heart failure, study finds.

A leading cause of death in Japan does not follow global medical conventions; why primary care clinicians should screen for gambling disorder; and a trial refutes vitamin C as a treatment for severe burns.

Anxiety and depression are linked to a higher risk for death and major adverse cardiovascular events, with a greater risk at higher symptom severity, prompting closer attention in routine care.

Gene therapy and small molecules are opening the door to new curative approaches, but access continues to be a barrier for most patients.

News All Time

Semaglutide Tablet Wins UK Approval for Weight Loss

The MHRA has approved the UK's first oral semaglutide tablet for obesity, with NHS availability pending a NICE evaluation.

Is Modern Medicine Losing the Art of Listening?

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, and the overall experience of care.

Extrahepatic Cancer Risk Varies by Liver Disease Subgroups

The risk for extrahepatic cancers varies among subgroups of steatotic liver disease, with the highest risk seen in patients with metabolic dysfunction and alcohol-associated liver disease.

New Deep Learning Model Parcellates Brain Using Only dMRI

A novel hierarchical deep learning framework enables direct Desikan-Killiany brain parcellation using only diffusion MRI-derived data, removing the need for structural scans.

ANTHEM-HFrEF: What Can We Learn From an Unfinished Trial?

Despite early termination, the ANTHEM-HFrEF trial holds important lessons for investigators.

How ‘Ozempic Mouth’ Became a Thing — and How to Treat It

GLP-1 medications may not directly cause oral health problems, but their mechanisms can. Take a cue from dental experts for insights on how to manage these oral effects.

Psoriasis Workup Expanding Beyond the Skin and Joints

The risk of some psoriasis-associated pathologies, such as cardiovascular disease, are better recognized than others.

What Is the Celebrity Effect? When Awareness Drives Action

From cancer to Parkinson's disease, public figures shape health perceptions in ways that few traditional awareness campaigns can achieve.

DAPT for 1 Month Tied to Lower Risk for NACE

Dual antiplatelet therapy for 1 month is tied to a lower risk for NACE after stent placement, with a greater drop in bleeding than increase in the risk for MI seen with longer use.

Exosomes Move Into the Regenerative Medicine Spotlight

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin rejuvenation, alopecia, and wound healing.

Ultraprocessing May Not Be ‘Inherently Harmful’

Randomized controlled trials provide ‘weak support’ for the idea that ultraprocessed foods are ‘inherently harmful’ simply because they are ultraprocessed.

Early Semaglutide After Bariatric Surgery Improves Outcomes

A prospective study finds that semaglutide initiated 1 month after sleeve gastrectomy is associated with greater weight loss at 1 year than surgery alone.

Groups Urge Delay to NHS Workforce Plan

NHS leaders have called for a pause to the workforce plan, warning it underestimates staffing needs and overstates AI benefits.

Waist Size and Muscle Mass: Predictors of Prognosis in CKD

In patients with CKD, lower muscle mass is linked to higher mortality and CKD progression, and higher visceral adiposity is linked to an increased risk for cardiovascular events, a recent study finds.

Lung Ultrasound Plus CRP May Guide Antibiotic Decisions

Lung ultrasound may help identify a bacterial component in children with acute lower respiratory tract infections and may guide antibiotic decisions when paired with C-reactive protein.

Stroke Treatment Outcomes Vary by Cancer Subtype

Patients with cancer who suffer an acute ischaemic stroke face higher odds of in-hospital death and bleeding after recanalisation therapy, with outcomes varying by cancer subtypes.

Recommended News For You

Spouses of Cancer Patients May Be at Increased Risk of Suicide

Weight loss trial reports success for breast cancer patients at one year mark

Prior authorizations draining time, energy from many cancer patients

More pain, more gain? New biopsy technique found to improve prostate cancer detection

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

Hereditary cancer has a rare and underreported cause.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Recommended Articles For You

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies 

Contemporary Advances in Hematology in the Digital Era 

Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers 

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

2.

Approved BTK Inhibitor Without Covalent Bond for CLL.

3.

Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment

4.

Use of social media during pregnancy may increase depression.

5.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

1.

Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts

2.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

3.

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment

4.

Unlocking the Potential of Palbociclib: A Comprehensive Overview

5.

The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

3.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

4.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

5.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot